Equities

Hunan Fangsheng Pharmaceutical Co Ltd

603998:SHH

Hunan Fangsheng Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)9.87
  • Today's Change0.04 / 0.41%
  • Shares traded4.21m
  • 1 Year change+5.90%
  • Beta--
Data delayed at least 15 minutes, as of Sep 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments202424272
Total Receivables, Net257379306
Total Inventory328303257
Prepaid expenses1066829
Other current assets, total27162.18
Total current assets9211,191867
Property, plant & equipment, net1,092873865
Goodwill, net274246379
Intangibles, net268274250
Long term investments268256197
Note receivable - long term1492642
Other long term assets------
Total assets3,0812,9222,704
LIABILITIES
Accounts payable11486107
Accrued expenses456165
Notes payable/short-term debt441310472
Current portion long-term debt/capital leases1962124
Other current liabilities, total453523587
Total current liabilities1,2481,0001,255
Total long term debt17429965
Total debt811629561
Deferred income tax353427
Minority interest131118108
Other liabilities, total368253
Total liabilities1,6231,5321,508
SHAREHOLDERS EQUITY
Common stock440439429
Additional paid-in capital186164132
Retained earnings (accumulated deficit)850817635
Treasury stock - common(17)(30)--
Unrealized gain (loss)(0.07)(0.07)--
Other equity, total----(0.07)
Total equity1,4581,3901,196
Total liabilities & shareholders' equity3,0812,9222,704
Total common shares outstanding439429429
Treasury shares - common primary issue1.159.880
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.